Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-18-002675

Options or other derivatives

  • Chief Operating Officer acquired 789,024 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bertrand William C JR Chief Operating Officer 2018-01-12 Grant or award · Option to purchase Ordinary Shares +644,976 644,976 D
Bertrand William C JR Chief Operating Officer 2018-01-12 Grant or award · Option to purchase Ordinary Shares +144,048 144,048 D
Loading xslF345X03/a4.xml…